The Unique and Evidence-Based Meningococcal Vaccine for Hajj and Umrah Pilgrims
DOI:
https://doi.org/10.31344/ijhhs.v9i10.779Keywords:
immunization, vaccination, pilgrimage, mass gathering, infectious diseaseAbstract
This lecture will delve into the significance of the unique, evidence-based meningococcal vaccine for pilgrims undertaking the Hajj and Umrah journeys. Meningococcal disease, caused by Neisseria meningitidis, poses a serious risk in the densely populated environments of these religious gatherings. The speaker will explore the epidemiology of meningococcal disease, particularly in the context of mass gatherings, and discuss the specific strains prevalent in the region. The session will highlight the development and approval of the meningococcal vaccine tailored for pilgrims, including its formulation, efficacy, and safety profile. Speaker will also review current vaccination guidelines mandated by international and local health authorities, and the importance of vaccination for all travellers to protect against outbreaks. Additionally, we will present recent evidence from studies demonstrating the vaccine’s effectiveness in preventing infections among pilgrims. By the end of this lecture, participants will gain a comprehensive understanding of the importance of the meningococcal vaccine, enabling them to advocate for its use and ensure the safety and well-being of pilgrims during their spiritual journeys.
International Journal of Human and Health Sciences Supplementary Issue 01: 2025 Page: S10
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Abdul Razak Bin Abdul Muttalif

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:
- Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.